100 top health apps, according to physicians

Laura Pedulli | | Health Exec | Precision Medicine

 

What health apps are the best? HealthTap surveyed more than 65,000 physicians within its network and 500,000 within its referral network on what they felt are the top 100 health apps on the market.

Apps that ranked the highest for Android operating systems included Weight Watchers Mobile (Weight Watchers International), White Noise Lite (TMSoft), Lose It! (FitNow); First Aid (American Red Cross); and RunKeeper (FitnessKeeper). Those most favored for the iOS operating system include Calorie Counter and Diet Tracker (MyFitnessPal); Weight Watchers Mobile; Lose It!; White Noise Lite; and First Aid.

The physicians ranked surveys based on their medical accuracy and effectivity; usability; and validity and soundness. The most common categories of health apps for both iOS and Android were tailored towared children’s health; healthy eating; and heart health, according to Politico.

Access the report.

 

Laura Pedulli

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.